Asia-Pacific Americas Africa Europe Middle East

GUJARAT THEMIS BIOSYN LIMITED

Company Profile:

Company Introduction:

Gujarat Themis Biosyn Limited (GTBL) is a prominent Indian pharmaceutical company. It specializes in the manufacturing of Active Pharmaceutical Ingredients (APIs) and advanced intermediates. GTBL operates as a joint venture between Themis Medicare Ltd. (India) and Yuhan Corporation (South Korea). The company is well-regarded for its capabilities in fermentation-based APIs and synthetic chemistry. Gujarat Themis Biosyn Limited is committed to delivering high-quality pharmaceutical products. It adheres to stringent international regulatory standards in its manufacturing processes. Its operations encompass research, development, and large-scale production, primarily serving the global pharmaceutical market.

Business Nature:

Factory (Manufacturer)

Enterprise Products

Here are some of the products manufactured and/or marketed by Gujarat Themis Biosyn Limited, based on publicly available information:

* Rifampicin

* Erythromycin

* Clarithromycin

* Azithromycin

* Other fermentation-based APIs (Active Pharmaceutical Ingredients)

Business Registration Information:

Manager:

Dr. Sachin D. Patel (Chairman & Managing Director of Themis Medicare Ltd., the parent company)
Phone:

+91 2668 262274 / 262334
E-mail:

marketing@themisbio.com
Official Website:
Address:

236/237/238, GIDC, WAGHODIA, DIST. VADODARA – 391 760, GUJARAT, INDIA
This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.